Loading...
CD81 is a novel immunotherapeutic target for B cell lymphoma
The tetraspanin CD81 was initially discovered by screening mAbs elicited against a human B cell lymphoma for their direct antiproliferative effects. We now show that 5A6, one of the mAbs that target CD81, has therapeutic potential. This antibody inhibits the growth of B cell lymphoma in a xenograft...
Na minha lista:
| Udgivet i: | J Exp Med |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Rockefeller University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6605745/ https://ncbi.nlm.nih.gov/pubmed/31123084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20190186 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|